Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1964 Aug;23(1):115-22.
doi: 10.1111/j.1476-5381.1964.tb01572.x.

THE EFFECTS OF BETHANIDINE ON THE PERIPHERAL CIRCULATION IN MAN

THE EFFECTS OF BETHANIDINE ON THE PERIPHERAL CIRCULATION IN MAN

J D FEWINGS et al. Br J Pharmacol Chemother. 1964 Aug.

Abstract

Bethanidine has been administered intra-arterially and intravenously into normotensive subjects and its effects on the limb blood vessels, arterial blood pressure, vascular sensitivity to noradrenaline and the degree and time course of sympathetic nerve blockade have been studied. The drug caused an initial constriction of hand and forearm vessels which is attributed to release of catechol amines since it is abolished by the prior administration of phenoxybenzamine. The constriction was followed by a sustained vasodilatation lasting between 5 and 20 hr. Sympathetic blockade of hand vessels commenced immediately on infusion and was complete within 1 hr of administration. Recovery occurred in about 5 hr. Sensitivity to intra-arterial noradrenaline was increased within 10 to 15 min of infusion and before sympathetic blockade was complete. Intravenous administration caused a slight rise in blood pressure of supine subjects. Baroreceptor reflex responses of heart and of limb vessels elicited by tilting the subject feet downwards were abolished by bethanidine and postural hypotension occurred. Bethanidine is a potent sympathetic blocking agent in man with properties intermediate between those of bretylium and guanethidine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol Chemother. 1963 Aug;21:165-73 - PubMed
    1. Clin Sci. 1961 Oct;21:151-5 - PubMed
    1. Lancet. 1963 Apr 6;1(7284):743-6 - PubMed
    1. J Physiol. 1954 Mar 29;123(3):62P-64P - PubMed
    1. Br J Pharmacol Chemother. 1963 Feb;20:36-55 - PubMed

LinkOut - more resources